Faculty

Institution

Unit

Venue

Travis P. Schrank

Assistant Professor

University of North Carolina at Chapel Hill

Affiliations

School of Medicine

Otolaryngology/head & Neck Surgery

Travis P. Schrank is currently serving as an Otolaryngology/Head & Neck Surgery Assistant Professor at University of North Carolina At Chapel Hill.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Travis P. Schrank

University of North Carolina at Chapel Hill

Assistant Professor

You can click a keyword to filter the displayed items

cancer research oncology cancer biology radiation oncology tumor biology molecular biology genetics cancer care cancer genomics medicinal research cancer treatment cancer genetics molecular cancer viral oncology oral cancer neck oncology epidemiology carcinogenesis gene expression cancer risk radiation biology otorhinolaryngology cancer management radiation cancer cells virus research clinical otolaryngology leukemia prognostic biomarkers radiation therapy racial discrimination race protein science thoracic oncology mammalian biology cancer disparities chromatin remodeling genitourinary cancers covid-19 pandemic clinical radiation oncology redox biology oral health oral diseases oral medicine animal physiology histopathology race relations ethnic discrimination protein phosphorylation racial equity racial studies health disparities experimental pathology mutagenesis molecular pathology general pathology mammalian physiology biomarker target reconstructive surgery cancer growth systematic analysis ethnic minorities case-matching analysis united states survival disparities human papillomavirus end-to-end distance tau protein ethnic disparities gain-of-function genetic screen white adipose tissue conditional mouse upper gastrointestinal tract proteomic quantitation predictive biomarkers thirty-day readmission

Notable Scholarly Works

Notable Federal Grants

Collaborators

423P Nf-κB Signaling Pathway Activity Leads to Identification of Novel Molecular Biomarkers in Hpv-Associated Head and Neck Cancer. Annals of Oncology (2024)

A. KothariT.P. SchrankW. YarbroughN. Issaeva

biomarkersbiomarker discoverycancer researchnovel molecular biomarkerspathway activitymolecular biologyoncologyhpv-associated headneck cancer

A Novel Compact Llm Framework for Local, High-Privacy Ehr Data Applications. arXiv (Cornell University) (2024)

Qu, YixiangDai, YifanYu, ShilinTanikella, PradhamSchrank, TravisHackman, TrevorLi, DidongWu, Di

privacy by designsystems engineeringbiomedical informaticsdata privacycommunication securityhealthcare big datadata managementhealth informaticsdata miningprivacy managementelectronic health recordsmachine learning researchdata scienceinformation securitybig datadata securitycomputer sciencedistributed data management

Arid1A Loss is Associated With Increased Nrf2 Signaling in Human Head and Neck Squamous Cell Carcinomas. PLoS ONE (2024)

Vinh NguyenTravis P. SchrankMichael B. MajorBernard E. Weissman

carcinogenesisredox signalingradiation oncologycancer researchplo biologyneck oncologyoral canceroncologyskin cancercancer biologypathologytumor biologycell biology

Association of Oropharyngeal Cancer Recurrence With Tumor-Intrinsic and Immune-Mediated Sequelae of Reduced Genomic Instability. bioRxiv (Cold Spring Harbor Laboratory) (2024)

Malay K. SannigrahiLovely RaghavDominick J. RichTravis P. SchrankJoseph A. CalifanoJohn N. LukensLova SunIain M. MorganRoger B. CohenAlexander LinXinyi LiuEric J. BrownJianxin YouLisa MirabelloSambit K. MishraDavid ShimunovRobert M BrodyAlexander T. PearsonPhyllis A. GimottyAhmed DiabJalal B. JalalyDevraj Basu

immunologycancer researchreduced genomic instabilityimmune-mediated sequelaeoropharyngeal cancer recurrence

De-Escalated Therapy and Early Treatment of Recurrences in Hpv-Associated Head and Neck Cancer: The Potential for Biomarkers to Revolutionize Personalized Therapy. Viruses (2024)

Wendell G. YarbroughTravis P. SchrankBarbara A. BurtnessNatalia Issaeva

medicineearly treatmentvirus-host interactionsvenereologyradiation oncologyepidemiologyvirologyoncologycancer-associated virusde-escalated therapycancer treatmentviral oncologypersonalized therapyviral diagnostics

Figure S4 From Nrf2 Activation in Trp53;P16-Deficient Mice Drives Oral Squamous Cell Carcinoma. (2024)

Samera H. HamadRani S. SellersNathan WamsleyPaul ZolkindTravis P. SchrankMichael B. MajorBernard E. Weissman

gene therapydermatologyleukemiapharmacologycancer geneticscancer researchmolecular cancercancer genomicscancer immunotherapycellular therapyoral cancertumor suppressorsoncologyoncogenesmedicinal researchcancer biologytumor biologycell biology

Molecular Characterization of the Salivary Adenoid Cystic Carcinoma Immune Landscape by Anatomic Subsites. Scientific Reports (2024)

Jason TasoulasTravis P. SchrankHarish BharambeJay MehtaSteven JohnsonKimon DivarisTrevor G. HackmanSiddharth ShethKedar KirtaneJuan C. Hernandez-PreraChristine H. ChungWendell G. YarbroughRenata FerrarottoNatalia IssaevaStamatios TheocharisAntonio L. Amelio

immunologyanatomic subsitesdermatologycancer researchmolecular biologycancer biologytumor biology

Nrf2 Activation in Trp53;P16 Deficient Mice Drives Oral Squamous Cell Carcinoma. Cancer research communications (2024)

Samera H. HamadRani S. SellersNathan WamsleyPaul ZolkindTravis P. SchrankMichael B. MajorBernard E. Weissman

tumor targetingmedicineleukemiapharmacologycancer carecancer geneticscancer researchcancer genomicscancer immunotherapytherapeutic targetscellular therapyoncologyoncogenesmedicinal researchcancer treatmentcancer biologytumor biologycell biology

Time to Treatment for Head and Neck Cancer Patients Decreased During the Early Phase of the Covid-19 Pandemic. Oral Oncology (2024)

Jason TasoulasGabrielle-Jaquelline AdamsTravis P SchrankChris B AgalaSiddharth ShethWendell G YarbroughTrevor HackmanChristopher Blake Sullivan

public healthtreatment and preventionmedicinesars-cov-2cancer careneck cancer patientscovid-19cancer managementcancer researchneck oncologysurgical oncologycovid-19 pandemicclinical trialsoncologyearly phasecancer treatmentcritical care

Abstract 2217: Novel Risk Stratification Utilizing Nanostring for Hpv+ Head and Neck Cancer Patients. Cancer Research (2023)

Sulgi KimTravis SchrankAditi KothariHina RehmaniJason TasoulasXue LiWendell YarbroughNatalia Isaeva

nanomedicinecancer carecancer managementradiation oncologycancer researchnovel risk stratificationoncologycancer treatmentcancer risk

1
2
3
4
5
10 / page

Travis P. Schrank

Assistant Professor

University of North Carolina at Chapel Hill

Affiliations

School of Medicine

Otolaryngology/head & Neck Surgery

Travis P. Schrank is currently serving as an Otolaryngology/Head & Neck Surgery Assistant Professor at University of North Carolina At Chapel Hill.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Travis P. Schrank

University of North Carolina at Chapel Hill

Assistant Professor

You can click a keyword to filter the displayed items

Notable Scholarly Works

Notable Federal Grants

Collaborators

423P Nf-κB Signaling Pathway Activity Leads to Identification of Novel Molecular Biomarkers in Hpv-Associated Head and Neck Cancer. Annals of Oncology (2024)

A. KothariT.P. SchrankW. YarbroughN. Issaeva

biomarkersbiomarker discoverycancer researchnovel molecular biomarkerspathway activitymolecular biologyoncologyhpv-associated headneck cancer

A Novel Compact Llm Framework for Local, High-Privacy Ehr Data Applications. arXiv (Cornell University) (2024)

Qu, YixiangDai, YifanYu, ShilinTanikella, PradhamSchrank, TravisHackman, TrevorLi, DidongWu, Di

Arid1A Loss is Associated With Increased Nrf2 Signaling in Human Head and Neck Squamous Cell Carcinomas. PLoS ONE (2024)

Vinh NguyenTravis P. SchrankMichael B. MajorBernard E. Weissman

carcinogenesisredox signalingradiation oncologycancer researchplo biologyneck oncologyoral canceroncologyskin cancercancer biologypathologytumor biologycell biology

Association of Oropharyngeal Cancer Recurrence With Tumor-Intrinsic and Immune-Mediated Sequelae of Reduced Genomic Instability. bioRxiv (Cold Spring Harbor Laboratory) (2024)

immunologycancer researchreduced genomic instabilityimmune-mediated sequelaeoropharyngeal cancer recurrence

De-Escalated Therapy and Early Treatment of Recurrences in Hpv-Associated Head and Neck Cancer: The Potential for Biomarkers to Revolutionize Personalized Therapy. Viruses (2024)

Wendell G. YarbroughTravis P. SchrankBarbara A. BurtnessNatalia Issaeva

Figure S4 From Nrf2 Activation in Trp53;P16-Deficient Mice Drives Oral Squamous Cell Carcinoma. (2024)

Samera H. HamadRani S. SellersNathan WamsleyPaul ZolkindTravis P. SchrankMichael B. MajorBernard E. Weissman

Molecular Characterization of the Salivary Adenoid Cystic Carcinoma Immune Landscape by Anatomic Subsites. Scientific Reports (2024)

immunologyanatomic subsitesdermatologycancer researchmolecular biologycancer biologytumor biology

Nrf2 Activation in Trp53;P16 Deficient Mice Drives Oral Squamous Cell Carcinoma. Cancer research communications (2024)

Samera H. HamadRani S. SellersNathan WamsleyPaul ZolkindTravis P. SchrankMichael B. MajorBernard E. Weissman

Time to Treatment for Head and Neck Cancer Patients Decreased During the Early Phase of the Covid-19 Pandemic. Oral Oncology (2024)

Jason TasoulasGabrielle-Jaquelline AdamsTravis P SchrankChris B AgalaSiddharth ShethWendell G YarbroughTrevor HackmanChristopher Blake Sullivan

Abstract 2217: Novel Risk Stratification Utilizing Nanostring for Hpv+ Head and Neck Cancer Patients. Cancer Research (2023)

Sulgi KimTravis SchrankAditi KothariHina RehmaniJason TasoulasXue LiWendell YarbroughNatalia Isaeva

nanomedicinecancer carecancer managementradiation oncologycancer researchnovel risk stratificationoncologycancer treatmentcancer risk

1
2
3
4
5
10 / page

Similar Faculty Members

Wendell G. Yarbrough

Institution

University of North Carolina at Chapel Hill

cancer letter

pathology

James Rocco

Institution

Ohio State University

oncology

cancer research

Umamaheswar Duvvuri

Institution

New York University

radiation oncology

neck pathology

Curtis R. Pickering

Institution

Yale University

cancer letter

pathology

Roger B. Cohen

Institution

University of Pennsylvania

oncology

radiation oncology

Mark W. Lingen

Institution

University of Chicago

oncology

cancer research

Seungwon Kim

Institution

University of Pittsburgh

cancer letter

advanced skin cancer

Wael Sakr

Institution

Wayne State University

iological traits

oncogene

Phyllis A. Gimotty

Institution

University of Pennsylvania

cancer research

cancer care

Heath Skinner

Institution

University of Pittsburgh

clinical radiation oncology

tp53 mutation

Similar Faculty Members

Wendell G. Yarbrough

Institution

University of North Carolina at Chapel Hill

cancer letter

pathology

James Rocco

Institution

Ohio State University

oncology

cancer research

Umamaheswar Duvvuri

Institution

New York University

radiation oncology

neck pathology

Curtis R. Pickering

Institution

Yale University

cancer letter

pathology

Roger B. Cohen

Institution

University of Pennsylvania

oncology

radiation oncology

Mark W. Lingen

Institution

University of Chicago

oncology

cancer research

Seungwon Kim

Institution

University of Pittsburgh

cancer letter

advanced skin cancer

Wael Sakr

Institution

Wayne State University

iological traits

oncogene

Phyllis A. Gimotty

Institution

University of Pennsylvania

cancer research

cancer care

Heath Skinner

Institution

University of Pittsburgh

clinical radiation oncology

tp53 mutation